Latest Earnings Results: Q3 '26
Estimated EPS
$0.30
Reported EPS
$0.51
Surprise
+71.35%
Estimated Rev
$178.06M
Reported Rev
$203.01M
Surprise
+14.01%
• Reported GAAP EPS of $0.51 down -23.88% YoY • Reported revenue of $203M up 41.15% YoY • TransMedics raised FY 2026 revenue guidance to $764M including PAD Aviation, with $750M excluding it; implied annual growth is 26% to 28% and 24% to 26%, respectively.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $0.44 | -- | -- | N/A |
Q3 '26 | $0.30 | $0.51 | 71.35% | BEAT |
Q2 '26 | $0.44 | $0.44 | -1.09% | MISSED |
Q1 '26 | $0.60 | $0.30 | -49.84% | MISSED |
Q4 '25 | $0.44 | $2.62 | 500.36% | BEAT |